Health, Jean-Luc Mélenchon
Medical deductibles: Repeal the 2024 increase in medical deductibles
Direction of change: decrease, compared with current law.
The lever. Sums left for the patient to pay on medicines, consultations and transport, not reimbursed by national health insurance (Assurance maladie). Direction rule: ↑ higher deductibles.
« Abroger la hausse des franchises médicales de 2024 »1Translation by the editorsRepeal the 2024 increase in medical deductibles
Encoding
Position linked to an option of the cost schedule, with no parameter to set: see the costing.
Costing
Announced by the candidate
not announced
The programme does not cost this measure.
Published costings
none
No external costing of this position recorded to date.
Our calculation
−€0.8bn
per year for the public accounts, revenue cut, range −€0.8bn to −€0.7bn.
The calculation
- Return to pre-2024 amounts: Option costed by the source: a cost of €0.8bn (0.7 to 0.8) per year.
Current law, sources and limits of the cost schedule
Current law. Charges (franchises) of €1 per box of medicine or paramedical procedure and €4 per transport; flat contribution of €2 per consultation or procedure (doubled in March and May 2024). Annual caps raised from €50 to €70 each, i.e. €140 combined instead of €100 (decree no. 2026-858 of 11 September 2026, from 1 October 2026). The €200 plan was abandoned.
Horizon. full year 2032, €bn/year
Limits. Abolition: central value and lower bound, €1.3bn (stable yield from 2009 to 2020, general scheme, REPSS) + €0.8bn (2024 doubling, government estimate) ≈ €2.1bn; upper bound, €1.5bn (2021 yield, REPSS) + 0.8 ≈ €2.3bn (editors' calculations). The values of €2.4bn and €2.8bn used until 18 October 2026 were not based on any cited source: withdrawn. The 2026 raising of the ceilings (yield not published) is not counted: it would slightly increase the cost of an abolition. A media outlet (Le Tribunal du Net) puts forward €2.5bn in 2025 without a checked primary source. The revenue figures are amounts due: €1.5bn of receivables remained to be collected at the end of 2024 (Cour des comptes, via iFRAP). Notable discrepancy: the PLFSS 2026 costed the initial plan (doubling of amounts and ceilings) at €2.3bn, while Caducée speaks of about €750m for the move to €200 alone.
- Le Quotidien du médecin, doublement des franchises (estimation gouvernementale), 2024-02: « la mesure devrait rapporter 800 millions d'euros aux caisses de la Sécurité sociale »
- Rapport d'évaluation des politiques de sécurité sociale (REPSS) Maladie, annexe 1 au PLACSS 2024, fiche 2.13.3 « Les participations forfaitaires et les franchises médicales » (page 213 du PDF), 2025: « En termes de rendement, il est possible de constater que le rendement total est resté stable entre 2009 et 2020, aux alentours de 1,3 Md€ par an pour le régime général. Les franchises représentent en moyenne 60 % de ce rendement sur la période. En 2021, il est possible d’observer une hausse marquée du rendement global, qui passe à près de 1,5 Md€ par an pour le régime général. »
- PLFSS 2026, annexe 5, 2025-10-14: « Hausse des plafonds et des montants sur les franchises et participations forfaitaires pour 2,3 Md€ ; doublement des montants et du plafond des franchises médicales (0,7 Md€) »
- service-public.gouv.fr, actualité A17166 (frais médicaux), décret n° 2026-858 du 11 septembre 2026, 2026-09: « Actuellement, le montant total des participations forfaitaires ne peut pas dépasser 50 € par an. […] À partir du 1er octobre 2026, ce plafond annuel est porté à 70 €. […] le montant total restant à charge au titre des franchises médicales et des participations forfaitaires pourra désormais atteindre 140 € par an, contre 100 € auparavant. […] Décret n° 2026-858 du 11 septembre 2026 relatif à la participation annuelle maximale des assurés aux frais de santé »
- Caducée.net, le gouvernement renonce aux 200 euros, 2026-08-25: « Franchises médicales et participations forfaitaires : 70 euros chacun, contre 50 euros actuellement ; maximum cumulé : 140 euros par an »
How to read these amounts. These are static costs and revenues, with no feedback effect, over a full year: nothing on growth, employment or the revenue that economic activity would gain or lose. A higher net cost does not on its own make a worse policy, nor net savings a better one: each programme rests on an economic model (demand-led stimulus, lower compulsory levies, consolidation of the public accounts…) that the cost schedule does not settle. GDP itself measures a volume of activity, not well-being or the usefulness of what is produced. Economic models and feedback effects.
- L’Avenir en commun, édition 2025 (La France insoumise), version 1 of 28 January 2025, p. 57. Open the document at this page.
Contest this encoding (prefilled email; procedure and deadlines)